Why a doctor cannot prescribe what my mother can

Time for DMC to relook and create a positive and forward looking policy that will harness India's advantage in the field of ayurveda

Sushmi Dey New Delhi
Last Updated : Sep 03 2014 | 9:31 AM IST
During my growing years, whenever I suffered from cough, cold or routine digestive disorders, my mother would readily provide me with home remedies comprising of ginger, Himalayan black salt, black cumin and ajwain. Generations have passed these time-tested recipes to younger generations.

My great grandmother shared these secrets with my grandmother and she then tutored my mother. While many of these recipes have disappeared with time, fortunately most of them have found credibility with several companies transforming them and developing clinically proven pharmaceutical products based on such herbs.
 
But the latest diktat by Delhi Medical Council (DMC) prohibiting allopathic doctors from prescribing ayurvedic medicines came as a shock. DMC’s order warns allopathic doctors from prescribing anything else other than allopathic medicines saying cross-pathy may lead to criminal charges against them.
 
So, by this rationale, allopathic doctors may face criminal charges even on prescribing exercise, walking or jogging.
 
Interestingly, all ayurvedic medicines in India are licensed products and are sold over-the-counter (OTC). This precisely means one does not require a prescription to buy products like Liv52, Honitus, Pudin Hara, Gripe Water etc. One of the main reasons for making ayurvedic medicines available over-the-counter is also because they do not have any side-effects.
 
However, DMC’s order overrules this idea. Instead, it prohibits a learned doctor from prescribing something which anyone can just walk in and buy from a retailer.
 
The move not only fails to gather rationale but also signals a mis-match with the Central government’s priorities. While the BJP-led NDA government is attempting to promote ‘desi’ products in domestic as well as overseas markets, DMC’s order may act as a major deterrent for doctors, consumers as well as companies like Dabur, Himalaya, Charak, Baidyanath and others investing in ayurveda.
 
The sacred knowledge of plant extracts used in treatment of various ailments has been with Indians for very long. And now the West too has started showing keen interest in these medicines that come without any side effects. 
 
While India is sitting on a rich variety of herbs and medicinal plants, countries like China have excelled in promoting the science of alternative medicines.
 
It is time for DMC to relook and try to create a positive and forward looking policy in sync with the government’s strategy.
 
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 02 2014 | 10:42 AM IST

Next Story